X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (744) 744
Publication (122) 122
Book Review (16) 16
Book Chapter (11) 11
Book / eBook (8) 8
Dissertation (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (578) 578
index medicus (474) 474
female (355) 355
male (335) 335
spontaneous clearance (323) 323
adult (281) 281
hepatitis c virus (263) 263
hepatitis c (255) 255
gastroenterology & hepatology (252) 252
middle aged (233) 233
genotype (182) 182
health aspects (181) 181
hepatitis (167) 167
infectious diseases (158) 158
infection (151) 151
remission, spontaneous (146) 146
genetic-variation (142) 142
hepacivirus - genetics (141) 141
interleukins - genetics (138) 138
interferon (136) 136
antiviral agents - therapeutic use (129) 129
viral load (129) 129
virus-infection (127) 127
immunology (117) 117
spontaneous viral clearance (115) 115
hepatitis c - virology (113) 113
virology (112) 112
il28b (111) 111
infections (110) 110
virus diseases (110) 110
treatment outcome (102) 102
genetic aspects (101) 101
risk factors (99) 99
hepatitis c - drug therapy (97) 97
analysis (95) 95
hiv (92) 92
aged (91) 91
polymorphism, single nucleotide (90) 90
young adult (87) 87
research (85) 85
hcv (84) 84
viruses (82) 82
hepatitis c, chronic - virology (79) 79
therapy (79) 79
hepatitis c - immunology (77) 77
liver (76) 76
hepatitis c, chronic - genetics (75) 75
natural-history (75) 75
ribavirin (75) 75
biological response modifiers (74) 74
hepacivirus - immunology (74) 74
rna, viral - blood (73) 73
viral clearance (71) 71
hepatitis c - genetics (70) 70
genome-wide association (68) 68
liver diseases (67) 67
care and treatment (66) 66
hepatitis c - epidemiology (66) 66
epidemiology (64) 64
gastroenterology and hepatology (64) 64
medicine (63) 63
hcv infection (62) 62
adolescent (61) 61
animals (60) 60
genotypes (60) 60
rna (60) 60
digestive system diseases (59) 59
hepatitis c, chronic - drug therapy (59) 59
hepatitis-c virus (59) 59
microbiology (59) 59
development and progression (57) 57
interferon-alpha - therapeutic use (57) 57
prevalence (55) 55
sustained virological response (55) 55
ribavirin - therapeutic use (54) 54
article (53) 53
hepacivirus - isolation & purification (52) 52
hepatitis c, chronic - immunology (51) 51
medical research (51) 51
pegylated interferon (50) 50
single nucleotide polymorphisms (50) 50
acute disease (49) 49
cytokines (49) 49
hepatitis c - complications (49) 49
alleles (48) 48
cohort studies (48) 48
research article (48) 48
time factors (48) 48
drug therapy, combination (47) 47
genotype & phenotype (47) 47
hepatitis c - diagnosis (47) 47
antiviral agents (46) 46
hepatitis c antibodies - blood (46) 46
hepatology (46) 46
plus ribavirin (46) 46
chronic infection (45) 45
disease progression (45) 45
hepatocellular-carcinoma (45) 45
polymorphism (45) 45
prospective studies (45) 45
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (749) 749
Chinese (3) 3
Spanish (3) 3
French (2) 2
Korean (2) 2
Japanese (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC INFECTIOUS DISEASES, ISSN 1471-2334, 07/2019, Volume 19, Issue 1, pp. 626 - 7
Background: In the United States Hepatitis C virus (HCV) viral clearance is estimated to range between 20 and 30%. The objective of this study was to estimate... 
KIDNEY-DISEASE | IMMUNITY | INFECTIOUS DISEASES | Spontaneous clearance | VIRUS-INFECTION | SEX | Epidemiology | GENETIC-VARIATION | IL28B | PRIMARY-CARE | BIOLOGY | PEOPLE | Hepatitis C | Viruses | Demographic aspects | Inactivation | Patient outcomes
Journal Article
PLoS Pathogens, ISSN 1553-7366, 09/2018, Volume 14, Issue 9, p. e1007290
Most individuals exposed to hepatitis C virus (HCV) become persistently infected while a minority spontaneously eliminate the virus. Although early immune... 
DETERMINANTS | PERSISTENCE | INFLUENZA | HUMANS | MICROBIOLOGY | INDUCTION | HCV INFECTION | CD8(+) T-CELLS | VIROLOGY | YELLOW-FEVER VACCINE | SYSTEMS-ANALYSIS | GENE-EXPRESSION | PARASITOLOGY | Hepacivirus - immunology | Humans | Middle Aged | Immunity, Innate - genetics | Transcriptome | Hepacivirus - pathogenicity | Male | Leukocytes, Mononuclear - virology | Host-Pathogen Interactions - immunology | Young Adult | Hepatitis C - immunology | Leukocytes, Mononuclear - immunology | Adult | Female | Dengue - immunology | Hepacivirus - isolation & purification | Acute Disease | Yellow Fever Vaccine - immunology | Hepatitis C - genetics | Viral Load - immunology | B-Lymphocytes - immunology | Sequence Analysis, RNA | Host-Pathogen Interactions - genetics | Hepatitis C - virology | Remission, Spontaneous | Longitudinal Studies | Immune response | Physiological aspects | Development and progression | Genetic aspects | Research | Genetic transcription | Hepatitis C | Drug abuse | Funding | Viral diseases | Immune clearance | Viruses | Leukocytes (mononuclear) | Infections | Genomes | Biology | Vaccines | Composition effects | Blood | Immunosuppressive agents | Hepatitis | Immunology | Lymphocytes | Peripheral blood mononuclear cells | Signatures | Bioinformatics | Immune system | Vector-borne diseases | Antiviral agents | Dengue | Exposure | Inflammation | Ribonucleic acid--RNA | Gene expression | Influenza | Interferon | Hepatitis C virus | RNA | Ribonucleic acid
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, p. e0146258
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 11, pp. e27555 - e27555
Since acute hepatitis C virus (HCV) infection is often asymptomatic, it is difficult to examine the rate and determinants of spontaneous clearance.... 
GENETIC-VARIATION | INJECTION-DRUG USERS | INTERFERON-ALPHA | SINGLE-SOURCE OUTBREAK | GENOTYPE | PERSISTENCE | DISEASE | BIOLOGY | INFECTION | PREVALENCE | NATURAL-HISTORY | Multivariate Analysis | Asymptomatic Infections - epidemiology | Humans | Genotype | Hepacivirus - pathogenicity | Hepatitis C - genetics | Male | Interleukins - genetics | Residence Characteristics - statistics & numerical data | Hepatitis C - epidemiology | Hepatitis C - virology | Sex Distribution | Adult | Female | Hepatitis C - complications | Remission, Spontaneous | Acute Disease - epidemiology | Behavior | Cohort Studies | Infection | Hepatitis C virus | Health aspects | Analysis | Health care | Drug abuse | Substance abuse treatment | Sexually transmitted diseases--STD | Laboratories | Identification methods | Communities | Health services | Genes | Sex | Chronic infection | Viruses | Infections | Methadone | Multivariate analysis | Synergism | Confidence intervals | Hepatitis | Signal transduction | Immunology | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Hemophilia | Hepatitis B virus | Genotypes | Public health | Statistical analysis | Cytokines | Genetic diversity | Regression analysis | Seroconversion | Disease control | Fever | Studies | Infectious diseases | Ligands | Determinants | Interferon | Hepatitis C | Females | Hepatitis B | Sociodemographics | Index Medicus | Sexually transmitted diseases | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 05/2012, Volume 97, Issue 5, pp. 679 - 686
Journal Article
Irish Medical Journal, ISSN 0332-3102, 2017, Volume 110, Issue 6, p. 582
Up to 40% of patients with hepatitis C virus (HCV) antibodies are negative for HCV RNA at initial evaluation. If there is a risk of viral re-activation, long... 
Recurrence | Follow-Up Studies | Hepacivirus - immunology | Humans | RNA, Viral - analysis | Hepatitis C Antibodies - analysis | Time Factors | Disease Outbreaks | Hepatitis C - epidemiology | Hepatitis C - virology | Female | Hepacivirus - physiology | Remission, Spontaneous | Virus Activation
Journal Article
Clinical and Molecular Hepatology, ISSN 2287-2728, 12/2014, Volume 20, Issue 4, pp. 368 - 375
Journal Article
Case Reports in Gastroenterology, ISSN 1662-0631, 08/2016, Volume 10, Issue 2, pp. 417 - 422
Following interferon-based therapy for chronic hepatitis C, the negativity of hepatitis C virus RNA is essential to achieve viral clearance at the end of... 
Single Case | Delayed viral clearance | IL28B | Spontaneous viral clearance | Hepatitis C | HLA | Peginterferon | Ribavirin
Journal Article
Clinical and Molecular Hepatology, ISSN 2287-2728, 12/2014, Volume 20, Issue 4, pp. 368 - 375
This study evaluated the predictors of spontaneous viral clearance (SVC), as defined by two consecutive undetectable hepatitis C virus (HCV) RNA tests... 
Spontaneous viral clearance | HCV RNA | Interferon | Acute hepatitis C | Recurrence | Acute Disease | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Middle Aged | Child, Preschool | Hepacivirus - genetics | Genotype | Male | RNA, Viral - blood | Young Adult | Hepatitis C - diagnosis | Adolescent | Adult | Female | Remission, Spontaneous | Aged | Child | Original
Journal Article